Supha Pharmachem Limited (BOM:539561)
0.2500
+0.0100 (4.17%)
At close: Oct 22, 2026
Supha Pharmachem Market Cap
Supha Pharmachem has a market cap or net worth of 100.8 million as of October 22, 2026. It is the 49,307th most valuable company in the world and the 5,176th biggest in India. Its market cap has decreased by 83.87% in one year.
Market Cap
100.80M
Enterprise Value
10.96B
Revenue
5.27B
Global Rank
Country Rank
#5,176 India
PE Ratio
1.34
ChartMarket Cap Chart
Since May 25, 2018, Supha Pharmachem's market cap has increased from 45.36M to 100.80M, an increase of 122.22%. That is a compound annual growth rate of 9.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 100.80M | -66.67% |
| Dec 31, 2025 | 302.40M | -85.35% |
| Dec 31, 2024 | 2.06B | -79.58% |
| Dec 29, 2023 | 10.11B | 1,895.62% |
| Dec 30, 2022 | 506.52M | 1.22% |
| Dec 31, 2021 | 500.40M | 194.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Panchsheel Organics | 1.37B |
| Krebs Biochemicals & Industries | 1.23B |
| Himalaya Nutravedics India | 1.18B |
| Tyche Industries | 1.06B |
| Crestchem | 490.95M |
| Vasundhara Rasayans | 432.39M |
| Alfavision Overseas (India) | 357.82M |
| Bacil Pharma | 291.94M |